Objective To observe effects of hemodiafiltration(HDF) and hemodialysis(HD)on uremic encephalopathy(UE).

目的观察血液过(HDF)及血液(HD)对尿毒症脑病的疗效。

The method basically has blood dialytic with peritonaeum dialytic two kinds.

方法主要有血液和腹膜两种。

To observe the influence of hemodiafiltration(HDF) on cardiovascular stability of older hemodialysis(HD) patients.

观察血液过(HDF)对老年患者心血稳定性的影响。

Objective To assesses the clinical value of tumor markers in haemodialysis patients and uremic patients.

摘要 摘要 目的：解血液和尿毒症对肿瘤标志物水平的影响。

Objective To evaluate the incidence of depress in hemodia lysis and peritoneal dialysis uremia patients.

目的 评价进行血液和腹膜治疗的尿毒症患 者抑郁症的发病情况。

Methods Observing 12 cases with hematodialysis by artificial blood vessel internal fistula, and giving nursing according internal fistula.

方法观察12例使用人造血行血液的患者,针对其情况进行护理。

Conclusion The hyponatremia patients can use hemodialysis when dieresis had no effect, combine heart failure or hypervolemia.

结论低钠血症患者如果利尿效果不佳或合并有心力衰竭或高血容量时,可以考虑血液治疗。

Objective To perspectively evaluate the prevalence and clinical characteristics of acquired cystic kidney disease and renal cell carcinoma in hemodialysis patients.

目的 提高对长期血液患者获得性肾囊肿及肾细胞癌的发病和临床特点的认识。

Objective To investigate the factor relateted to the prognosis in HFRS patients with ARF oliguresis stage and the applied chance of hemodiaglysis in HFRS patients.

目的探讨影响出血热病人急性肾衰少尿期预后的因素及血液在出血热病人中的应用时机。

Objective To investingate the clinical effect of Shenkang injection in treating chronic renal failure and control process of it,slowing down and decreasing the numbers of dialyses.

目的观察肾康注射液治疗慢性肾功能衰竭的疗效,为控制慢性肾衰患者肾衰进程而延缓进行血液提供一个好的方法。